Search PDMR transactions

Notifier
Name
Magnus Hansson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Magnus Hansson
Position
Chief Medical Officer
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
NeuroVive Pharmaceutical AB
LEI code
5493005YV22OTMUHZ183
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
BTA NeuroVive Pharmaceutical AB BTA SE0005620341 Subscription 206,673 Quantity 1.35 SEK 06/02/2019 NASDAQ STOCKHOLM AB
Aggregation
Name ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
NeuroVive Pharmaceutical AB BTA SE0005620341 Subscription 06/02/2019 NASDAQ STOCKHOLM AB 206,673 (Quantity) 1.35 SEK
<< Back